Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors

Abstract

BackgroundBetulinic acid (BA) inhibits growth of several cancer cell lines and tumors and the effects of BA have been attributed to its mitochondriotoxicity and inhibition of multiple pro-oncogenic factors. Previous studies show that BA induces proteasome-dependent degradation of specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 in prostate cancer cells and this study focused on the mechanism of action of BA in colon cancer cells.MethodsThe effects of BA on colon cancer cell proliferation and apoptosis and tumor growth in vivo were determined using standardized assays. The effects of BA on Sp proteins and Sp-regulated gene products were analyzed by western blots, and real time PCR was used to determine microRNA-27a (miR-27a) and ZBTB10 mRNA expression.ResultsBA inhibited growth and induced apoptosis in RKO and SW480 colon cancer cells and inhibited tumor growth in athymic nude mice bearing RKO cells as xenograft. BA also decreased expression of Sp1, Sp3 and Sp4 transcription factors which are overexpressed in colon cancer cells and decreased levels of several Sp-regulated genes including survivin, vascular endothelial growth factor, p65 sub-unit of NFκB, epidermal growth factor receptor, cyclin D1, and pituitary tumor transforming gene-1. The mechanism of action of BA was dependent on cell context, since BA induced proteasome-dependent and proteasome-independent downregulation of Sp1, Sp3 and Sp4 in SW480 and RKO cells, respectively. In RKO cells, the mechanism of BA-induced repression of Sp1, Sp3 and Sp4 was due to induction of reactive oxygen species (ROS), ROS-mediated repression of microRNA-27a, and induction of the Sp repressor gene ZBTB10.ConclusionsThese results suggest that the anticancer activity of BA in colon cancer cells is due, in part, to downregulation of Sp1, Sp3 and Sp4 transcription factors; however, the mechanism of this response is cell context-dependent.

Suppression of Cellular Apoptosis Susceptibility (CSE1L) Inhibits Proliferation and Induces Apoptosis in Colorectal Cancer Cells

“…It was estimated around one million cases of colon cancer are diagnosed per year (Chintharlapalli et al, 2011). Although several therapies such as surgery, ablation, chemotherapy and chryotherapy continue to emerge, yet it remains the second cause of cancer related death.…”

New composites of betulin esters with arabinogalactan as highly potent anti-cancer agents

“…The inhibitory effect of betulinic acid and its derivatives only on cancer cells has been already described in many studies (Chintharlapalli et al 2011;Potze et al 2014). Previously we showed antitumor activity of BDA-AG complexes that activated apoptosis in murine Ehrlich ascites tumor cells by increasing the concentration of intracellular calcium and sodium (Shakhtshneider et al 2013).…”

The flavonoid resveratrol suppresses growth of human malignant pleural mesothelioma cells through direct inhibition of specificity protein 1

“…Columns, mean of 10 mice tumor sections; bars, SD; * P<0.05, statistically significant differences from untreated group; bar, 100 µm. and selectively inhibit transcription of genes including c-myc, p27, p21, cyclin D1, Mcl-1 and survivin (8,(28)(29)(30). We expected that Res as a chemotherapeutic agent, also inhibits the level of Sp1 and regulates Sp1 target proteins such as p27, p21, cyclin D1, Mcl-1 and survivin.…”